{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:37:39Z","timestamp":1740112659091,"version":"3.37.3"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["#DK104006"],"award-info":[{"award-number":["#DK104006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.amjcard.2018.11.020","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T11:00:26Z","timestamp":1543057226000},"page":"598-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-8597","authenticated-orcid":false,"given":"James B.","family":"Wetmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiannong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.11.020_bib0001","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2010050459","article-title":"The increasing prevalence of atrial fibrillation among hemodialysis patients","volume":"22","author":"Winkelmayer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ki.2011.416","article-title":"The prevalence of and factors associated with chronic atrial fibrillation in Medicare\/Medicaid-eligible dialysis patients","volume":"81","author":"Wetmore","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0003","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.112.099606","article-title":"Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States","volume":"126","author":"Goldstein","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0004","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end-stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0005","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2012111077","article-title":"Stroke and the \"stroke belt\" in dialysis: contribution of patient characteristics to ischemic stroke rate and its geographic variation","volume":"24","author":"Wetmore","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.115.018294","article-title":"Risks of death and stroke in patients undergoing hemodialysis with new-onset atrial fibrillation: a competing-risk analysis of a nationwide cohort","volume":"133","author":"Shih","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0007","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrneph.2014.48","article-title":"Cardiovascular disease: still unresolved: warfarin in ESRD with atrial fibrillation","volume":"10","author":"Winkelmayer","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0008","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.2215\/CJN.08610816","article-title":"Use of oral anticoagulation for patients with ESRD on hemodialysis with atrial fibrillation. Verdict 1","volume":"11","author":"Bansal","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0009","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2215\/CJN.09470916","article-title":"Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: verdict 2","volume":"11","author":"Herzog","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0010","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2215\/CJN.09230816","article-title":"Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: verdict 3","volume":"11","author":"Rigatto","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0011","first-page":"S1","article-title":"US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States","volume":"71","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0012","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/106286069901400607","article-title":"Identifying persons with diabetes using Medicare claims data","volume":"14","author":"Hebert","year":"1999","journal-title":"Am J Med Qual"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0013","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.ajkd.2017.10.025","article-title":"Factors associated with withdrawal from maintenance dialysis: a case-control analysis","volume":"71","author":"Wetmore","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0014","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2215\/CJN.11651115","article-title":"Geovariation in fracture risk among patients receiving hemodialysis","volume":"11","author":"Wetmore","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2015.05.019","article-title":"Outcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillation","volume":"66","author":"Shen","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0016","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000331067","article-title":"Epidemiology of interdialytic ambulatory hypertension and the role of volume excess","volume":"34","author":"Agarwal","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0017","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ndt\/gfw433","volume":"32","author":"Sarafidis","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0018","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0037-1621715","article-title":"Direct oral anticoagulants in end-stage renal disease","volume":"44","author":"Klil-Drori","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0019","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.jacc.2016.02.082","article-title":"Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF","volume":"67","author":"Chan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2014.161","article-title":"Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010","volume":"1","author":"Zeng","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0021","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamasurg.2015.0287","article-title":"Racial\/ethnic disparities associated with initial hemodialysis access","volume":"150","author":"Zarkowsky","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0022","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/M16-1256","article-title":"Coverage and access for americans with chronic disease under the Affordable Care Act: a quasi-experimental study","volume":"166","author":"Torres","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0023","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M17-0102","article-title":"46-year trends in systemic lupus erythematosus mortality in the United States, 1968 to 2013: a nationwide population-based study","volume":"167","author":"Yen","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2018.11.020_bib0024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5301\/jn.5000010","article-title":"Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis","volume":"25","author":"Winkelmayer","year":"2012","journal-title":"J Nephrol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918321015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918321015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:39:12Z","timestamp":1565253552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918321015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0002914918321015"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.11.020","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}